A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-β in the host response to Pseudomonas aeruginosa lung infection in mice

被引:57
作者
Power, Melanie R.
Li, Bo
Yamamoto, Masahiro
Akira, Shizuo
Lin, Tong-Jun
机构
[1] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada
[2] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada
[3] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan
关键词
D O I
10.4049/jimmunol.178.5.3170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-IL-1R domain-containing adaptor-induicing IFN-beta (TRIF) is an adaptor molecule that mediates a distinct TLR signaling pathway. Roles of TRIF in the host defense have been primarily associated with virus infections owing to the induction of IFN-alpha beta. In this study, we investigated a role of TRIF in Pseudomonas aeruginosa infection. In vitro, TRIF-deficient mouse alveolar and peritoneal macrophages showed a complete inhibition of RANTES (CCL5) production, severely impaired TNF and KC (CXCL1) production, and reduced NF-kappa B activation in response to P. aeruginosa stimulation. In vivo, TRIF-deficient mice showed a complete inhibition of RANTES production, a severely impaired TNF and KC production, and an efficient MIP-2 and IL-1 beta production in the lung following P. aeruginosa infection. This outcome was associated with a delayed recruitment of neutrophils into the airways. These results suggest that TRIF mediates a distinct cytokine/chemokine profile in response to P. aeruginosa infection. P. aeruginosa-induced RANTES production is completely dependent on TRIF pathway in mice. Importantly, TRIF deficiency leads to impaired clearance of P. aeruginosa from the lung during the initial 24-48 h of infection. Thus, TRIF represents a novel mechanism involved in the development of host response to P. aeruginosa infection.
引用
收藏
页码:3170 / 3176
页数:7
相关论文
共 42 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5 [J].
Adamo, R ;
Sokol, S ;
Soong, G ;
Gomez, MI ;
Prince, A .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 30 (05) :627-634
[3]   RANTES: a versatile and controversial chemokine [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2001, 22 (02) :83-87
[4]   Is there a future for TNF promoter polymorphisms? [J].
Bayley, JP ;
Ottenhoff, THM ;
Verweij, CL .
GENES AND IMMUNITY, 2004, 5 (05) :315-329
[5]  
BERGER M, 1991, CLIN REV ALLERG, V9, P119
[6]   Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large [J].
Beutler, Bruce ;
Jiang, Zhengfan ;
Georgel, Philippe ;
Crozat, Karine ;
Croker, Ben ;
Rutschmann, Sophie ;
Du, Xin ;
Hoebe, Kasper .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :353-389
[7]   The induction of macrophage gene expression by LPS predominantly utilizes Myd88-dindependent signaling cascades [J].
Björkbacka, H ;
Fitzgerald, KA ;
Huet, F ;
Li, XM ;
Gregory, JA ;
Lee, MA ;
Ordija, CM ;
Dowley, NE ;
Golenbock, DT ;
Freeman, MW .
PHYSIOLOGICAL GENOMICS, 2004, 19 (03) :319-330
[8]   PULMONARY IMMUNITY TO PSEUDOMONAS-AERUGINOSA [J].
CRIPPS, AW ;
DUNKLEY, ML ;
CLANCY, RL ;
KYD, J .
IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (05) :418-424
[9]   Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation [J].
Cusson-Hermance, N ;
Khurana, S ;
Lee, TH ;
Fitzgerald, KA ;
Kelliher, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (44) :36560-36566
[10]   TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-β, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo [J].
De Trez, C ;
Pajak, B ;
Brait, M ;
Glaichenhaus, N ;
Urbain, J ;
Moser, M ;
Lauvau, G ;
Muraille, E .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :839-846